The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders

The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders Publisher

Rasmi Y^{1, 2} ; Shokati A^{3, 4, 5} ; Hassan A^{6, 7} ; Aziz SGG^{1, 2} ; Bastani S⁸ ; Jalali L² ; Moradi F⁹ ; Alipour S^{1, 2, 10}

Show Affiliations

1. Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran
2. Department of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
3. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran
5. Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
6. Dipartimento di Oncologia ed Emato-Oncologia, Universita Degli Studi Di Milano, Via Festa del Perdono, Milano, Italy
7. Laboratory of Translatonal Neurosciences, European School of Molecular Medicine, CEINGE Biotecnologie Avanzate S.c.a.rl.Via Gaetano Salvatore, Naples, Italy
8. Stem cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
9. Tissue Engineering and Applied Cell Sciences Division, Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
10. Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran

Source: IBRO Neuroscience Reports Published:2023

Abstract

Genome-wide studies related to neurological disorders and neurodegenerative diseases have pointed to the role of epigenetic changes such as DNA methylation, histone modification, and noncoding RNAs. DNA methylation machinery controls the dynamic regulation of methylation patterns in discrete brain regions. Objective: This review aims to describe the role of DNA methylation in inhibiting and progressing neurological and neurodegenerative disorders and therapeutic approaches. Methods: A Systematic search of PubMed, Web of Science, and Cochrane Library was conducted for all qualified studies from 2000 to 2022. Results: For the current need of time, we have focused on the DNA methylation role in neurological and neurodegenerative diseases and the expression of genes involved in neurodegeneration such as Alzheimer's, Depression, and Rett Syndrome. Finally, it appears that the various epigenetic changes do not occur separately and that DNA methylation and histone modification changes occur side by side and affect each other. We focused on the role of modification of DNA methylation in several genes associated with depression (NR3C1, NR3C2, CRHR1, SLC6A4, BDNF, and FKBP5), Rett syndrome (MECP2), Alzheimer's, depression (APP, BACE1, BIN1 or ANK1) and Parkinson's disease (SNCA), as well as the co-occurring modifications to histones and expression of non-coding RNAs. Understanding these epigenetic changes and their interactions will lead to better treatment strategies. Conclusion: This review captures the state of understanding of the epigenetics of neurological and neurodegenerative diseases. With new epigenetic mechanisms and targets undoubtedly on the horizon, pharmacological modulation and regulation of epigenetic processes in the brain holds great promise for therapy. © 2022 The Authors

Related Docs

View other Related Docs

1. Dna Methylation in Human Diseases, Heliyon (2024)

2. Future Challenges and Prospects for the Epigenetics of Autoimmunity, The Epigenetics of Autoimmunity (2018)

3. Prenatal Risk Factors and Genetic Causes of Adhd in Children, World Journal of Pediatrics (2022)

4. Epigenetic Modifications Associated With Pathophysiological Effects of Lead Exposure, Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews (2019)

5. Environmental Toxicants, Incidence of Degenerative Diseases, and Therapies From the Epigenetic Point of View, Archives of Toxicology (2017)

6. Evaluation of Dna Methylation in Bdnf, Slc6a4, Nr3c1 and Fkbp5 Before and After Treatment With Selective Serotonin-Reuptake Inhibitor in Major Depressive Disorder, Epigenomics (2022)

7. Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?, Life Sciences (2020)

8. The Effects of Exercise on Epigenetic Modifications: Focus on Dna Methylation, Histone Modifications and Non-Coding Rnas, Human Cell (2024)

Experts (# of related papers)

View all Related Experts

Seyed Hamidollah Ghaffari (3)

Nima Rezaei (2)

Style	Citing Format
MLA	Rasmi Y, et al.. "The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders." IBRO Neuroscience Reports, vol. 14, no. , 2023, pp. 28-37.
APA	Rasmi Y, Shokati A, Hassan A, Aziz SGG, Bastani S, Jalali L, Moradi F, Alipour S (2023). The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders. IBRO Neuroscience Reports, 14(), 28-37.
Chicago	Rasmi Y, Shokati A, Hassan A, Aziz SGG, Bastani S, Jalali L, Moradi F, Alipour S. "The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders." IBRO Neuroscience Reports 14, no. (2023): 28-37.
Harvard	Rasmi Y et al. (2023) 'The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders', IBRO Neuroscience Reports, 14(), pp. 28-37.
Vancouver	Rasmi Y, Shokati A, Hassan A, Aziz SGG, Bastani S, Jalali L, et al.. The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders. IBRO Neuroscience Reports. 2023;14():28-37.
BibTex	@article{ author = {Rasmi Y and Shokati A and Hassan A and Aziz SGG and Bastani S and Jalali L and Moradi F and Alipour S}, title = {The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders}, journal = {IBRO Neuroscience Reports}, volume = {14}, number = {}, pages = {28-37}, year = {2023} }
RIS	TY - JOUR AU - Rasmi Y AU - Shokati A AU - Hassan A AU - Aziz SGG AU - Bastani S AU - Jalali L AU - Moradi F AU - Alipour S TI - The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders JO - IBRO Neuroscience Reports VL - 14 IS - SP - 28 EP - 37 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract